Max Robotics — Global Service Robot Directory + US Certification

About

Epameinondas Dogeas is a surgical oncologist whose research focuses on advancing minimally invasive techniques for hepatopancreatobiliary (HPB) surgery, particularly robotic and laparoscopic approaches. His major contributions center on evaluating the safety, efficacy, and comparative outcomes of robotic versus open surgery for complex pancreatic and liver procedures. In his highly cited 2022 study on pancreaticoduodenectomy for benign and premalignant disease, Dogeas demonstrated that robotic surgery offers superior perioperative outcomes, including reduced blood loss and shorter hospital stays, challenging traditional open approaches. His 2023 work on neoadjuvant chemotherapy’s impact on laparoscopic and robotic liver resections for colorectal metastases, using rigorous propensity-score and coarsened exact matching, provides critical evidence that these minimally invasive techniques remain safe and effective even in challenging oncologic contexts. With over 13 citations across these key papers, Dogeas’s research is shaping clinical guidelines and expanding the role of robotic surgery in HPB oncology. His work is particularly notable for its methodological rigor, employing advanced statistical matching to minimize selection bias, making his findings highly influential for surgeons and researchers seeking to optimize surgical care for patients with pancreatic and liver diseases.